Microvessel Density and Prostate Cancer Survival
Author Information
Author(s): M Borre, BV Offersen, B Nerstr0m, J Overgaard
Primary Institution: Danish Cancer Society, University Hospital of Aarhus
Hypothesis
Does microvessel density at diagnosis correlate with disease-specific survival in prostate cancer patients?
Conclusion
Microvessel density is a significant predictor of disease-specific survival in prostate cancer patients subjected to watchful waiting.
Supporting Evidence
- Microvessel density was significantly associated with clinical stage and histopathological grade.
- MVD was a significant predictor of disease-specific survival in both the entire population and the clinically localized subpopulation.
- 98% of patients had died by the end of the follow-up period, with 57% dying from prostate cancer.
Takeaway
This study found that counting the tiny blood vessels in prostate tumors can help predict how long patients might live after diagnosis.
Methodology
Microvessel density was quantified in tumor samples from 221 prostate cancer patients using immunohistochemical methods.
Potential Biases
Potential biases due to retrospective data collection and the lack of standardized methods for measuring microvessel density.
Limitations
The study is retrospective and relies on previously collected data, which may introduce inaccuracies.
Participant Demographics
Median age of participants was 75 years, with a range from 49 to 95 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 2.17-6.82
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website